Rapid Communication - Journal of Molecular Oncology Research (2023) Volume 7, Issue 4
The leukemia-related bone marrow microenvironment is under the control of metabolism.
Zhao Li *
Department of Hematology, Southern Medical University, Guangzhou, China
- *Corresponding Author:
- Zhao Li
Department of Hematology
Southern Medical University
Guangzhou, China
E-mail: Email:zhao@li.com.cn
Received:23-Jun-2023, Manuscript No. AAMOR-23-104096; Editor assigned:26-Jun-2023, PreQC No. AAMOR-23-104096 (PQ); Reviewed:10-July-2023, QC No. AAMOR-23-104096; Revised:15-July-2023, Manuscript No. AAMOR-23-104096 (R); Published:24-July-2023, DOI:10.35841/ aamor-7.4.181
Citation: Li Z. The leukemia-related bone marrow microenvironment is under the control of metabolism. J Mol Oncol Res. 2023; 7(4):181
Abstract
Introduction
The primary role of the Bone Marrow's (BM) microenvironment is to transmit signals that control and promote the creation of the billions of blood cells required for homeostasis. Leukemia, a type of cancer that affects the blood and bone marrow, is a complex and multifaceted disease. The understanding of leukemia has evolved over the years, and recent research has shed light on the critical role of the bone marrow microenvironment in the development and progression of the disease. The microenvironment, consisting of various cellular and non-cellular components, provides a nurturing environment for leukemia cells to thrive and evade the immune system. Emerging evidence suggests that the metabolic processes within the bone marrow microenvironment play a crucial role in regulating the behavior of leukemia cells. Metabolism, the set of biochemical reactions that occur in living organisms to sustain life, has been implicated in controlling the dynamics of the leukemia-related bone marrow microenvironment [1].
Leukemia, a group of malignant blood disorders, is characterized by the uncontrolled proliferation of abnormal white blood cells within the bone marrow. While the genetic and molecular aspects of leukemia have been extensively studied, recent research has shed light on the crucial role played by the bone marrow microenvironment in the development and progression of this disease [2].
In addition to genetic and cellular factors, it is becoming increasingly evident that metabolic processes play a pivotal role in regulating the dynamics of the leukemia-related bone marrow microenvironment. Metabolism, the sum of all chemical reactions occurring within cells, provides the necessary energy and building blocks for cell growth, proliferation, and survival. Alterations in metabolic pathways can profoundly impact the functioning of both leukemia cells and the non-malignant cells present in the bone marrow microenvironment [3].
The metabolic control of the leukemia-related bone marrow microenvironment has significant implications for the development of novel therapeutic strategies. Targeting specific metabolic vulnerabilities within leukemia cells or modifying the metabolic interactions between leukemic cells and their niche could potentially disrupt disease-supportive mechanisms and enhance the efficacy of existing treatments. This review aims to provide an overview of the current understanding of how metabolism influences the leukemia-related bone marrow microenvironment. By exploring the metabolic interactions between leukemia cells and their surrounding niche, we hope to highlight potential avenues for therapeutic intervention and advance our knowledge of leukemia biology [4].
The intricate relationship between metabolism and the leukemia-related bone marrow microenvironment has emerged as a critical aspect of leukemia biology. Metabolic processes regulate the dynamic interplay between leukemia cells and their niche, influencing disease progression, treatment response, and therapeutic resistance. Understanding the metabolic control of the leukemia-related bone marrow microenvironment has significant implications for the development of innovative treatment strategies. The control of the leukemia-related bone marrow microenvironment by metabolism represents an exciting avenue for research and therapeutic development. The exploration of metabolic dependencies and vulnerabilities within leukemia cells, as well as the modulation of metabolic interactions between leukemia cells and their niche, holds immense promise for improving outcomes for leukemia patients. Continued efforts to unravel the metabolic intricacies of the leukemia-related bone marrow microenvironment will undoubtedly contribute to advancing our understanding of leukemia biology and pave the way for innovative therapeutic interventions [5].
References
- Tikhonova AN, Dolgalev I, Hu H, et al. The bone marrow microenvironment at single-cell resolution. Nature. 2019;569(7755):222-8.
- Shafat MS, Gnaneswaran B, Bowles KM, et al. The bone marrow microenvironment–Home of the leukemic blasts. Blood Rev. 2017;31(5):277-86.
- Yan D, Franzini A, Pomicter AD, et al. SIRT5 is a druggable metabolic vulnerability in acute myeloid leukemia. Blood Cancer Disc. 2021;2(3):266-87.
- Meads MB, Hazlehurst LA, Dalton WS. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res. 2008;14(9):2519-26.
- Podar K, Chauhan D, Anderson KC. Bone marrow microenvironment and the identification of new targets for myeloma therapy.. Leukemia. 2009;23(1):10-24.
Indexed at, Google Scholar,Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref